ReviewCureus2025
A Review of the Long-Term Cardiovascular Consequences of Hypertensive Disorders of Pregnancy.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypertensive disorders of pregnancy (HDP) are a major worldwide issue, affecting 5-10% of pregnancies and causing feto-maternal mortality and morbidity. It includes chronic, gestational hypertension, preeclampsia, and chronic hypertension with preeclampsia. The underlying pathophysiology includes aberrant placental perfusion, angiogenic imbalance, endothelial dysfunction, and hereditary susceptibility. Women with HDP face a markedly increased risk of cardiovascular disease, chronic renal disease, and metabolic syndrome, with larger connections than those with gestational diabetes. Measures such as early aspirin prophylaxis, lifestyle modifications, and prompt antihypertensive therapy are beneficial, but adherence remains low. Postpartum monitoring is generally underused, despite its importance in reducing future cardiovascular risk. Addressing these gaps is critical for lowering maternal mortality, avoiding recurring problems, and improving health outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.